Opportunities Preloader

Please Wait.....

Report

Fosun International Ltd (00656:HKG) - Strategic SWOT and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends

Company Report I 2025-12-24 I 85 Pages I Quaintel Research

Report Summary

Fosun International Ltd Strategic SWOT Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Fosun International Ltd's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Fosun International Ltd including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Fosun International Ltd's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Fosun International Ltd's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Fosun International Ltd's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Fosun International Ltd's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Fosun International Ltd enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Fosun International Ltd is a diversified global investment and industrial group headquartered in Hong Kong, founded in 1992 by Guo Guangchang and several partners. The company operates through multiple core segments, including Health, Happiness, Wealth, and Intelligent Manufacturing, creating a broad portfolio across pharmaceuticals, medical services, tourism, insurance, asset management, and consumer brands. Fosun s strategy focuses on the concept of the global ecosystem, combining industrial operations with investment capabilities to build synergies across markets.In the Health segment, Fosun invests in pharmaceuticals, medical devices, and healthcare services, supporting its mission of delivering accessible medical solutions. Its Happiness segment includes tourism, fashion, and lifestyle brands, highlighted by holdings such as Club Med. The Wealth segment covers insurance, asset management, and financial services, while Intelligent Manufacturing supports advanced materials and high-tech industrial operations.With a strong global footprint spanning Europe, Asia, and the Americas, Fosun aims to drive long-term growth through innovation, globalization, and strategic investments.

Fosun International Ltd in the News:-

2025-08-22 - First Subject Dosed in the US for a Phase 2 International Clinical Trial of Henlius PD-L1 ADC HLX43 for NSCLC
2025-08-07 - Henlius to Initiate a Phase 1 Multicenter Study in US of Its PD-L1 ADC HLX43 for the Treatment of Thymic Carcinoma
2025-07-21 - Club Med appoints Stephane Maquaire as President and CEO
2025-06-24 - Serplulimab Approved in the UK and India for the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
2025-05-29 - Fosun Pharma s Self-Developed Innovative Drug Luvometinib Tablet Approved in China


Scope

- Tactical Analysis:- Various strategic frameworks to gain insights into a Fosun International Ltd's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the Fosun International Ltd's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the Fosun International Ltd's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

- Comprehensive Understanding of the Fosun International Ltd's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Fosun International Ltd:

- Fosun International Ltd PESTLE Analysis
- Fosun International Ltd Value Chain Analysis
- Fosun International Ltd Porter's Five Forces Analysis
- Fosun International Ltd VRIO Analysis
- Fosun International Ltd BCG Analysis
- Fosun International Ltd Segmentation, Targeting and Positioning (STP) Analysis
- Fosun International Ltd Ansoff Matrix Analysis

Table of Contents 2
Tables 5
Charts 6
Fosun International Ltd - Key Company Facts 7
Fosun International Ltd - Company Description 8
Fosun International Ltd - Top Executives 9
Fosun International Ltd- Head Office & Locations 10
Head Office - Country 10
Fosun International Ltd - Products and Services 11
Products 11
Services 12
Fosun International Ltd - Company's Mission and Vision 13
Mission 13
Fosun International Ltd - Corporate Strategy 14
Fosun International Ltd - Business Description 17
Health segment 18
Happiness Segment 18
Wealth Segment 19
Intelligent Manufacturing Segment 20
Fosun International Ltd - ESG Spotlight 21
Environment 21
Social 22
Corporate Governance 23
Fosun International Ltd - SWOT Analysis 24
Overview 24
Strengths 26
Weaknesses 29
Opportunities 31
Threats 33
Fosun International Ltd - Financial Deep Dive 35
Share Price Trend - Dec-2024to Dec-2025 (Average Share Closing Price) 35
Profit and Loss Statement 37
Summary of Profit and Loss Statement 37
Balance Sheet 39
Summary of Balance Sheet 39
Cash Flow Statement 41
Summary of Cash Flow Statement 41
Key Financial Ratio Analysis 43
Fosun International Ltd - Ratio Charts 44
Activity Ratio Charts 44
Growth Ratios Charts 45
Leverage Ratio Charts 46
Liquidity Ratio Charts 47
Profitability Ratio Charts 48
Competing Players 49
Snapshot of Competing Players 50
China Everbright Ltd 50
Key Company Facts 50
Company Description 50
Snapshot of Competing Players 51
Marriott International Inc 51
Key Company Facts 51
Company Description 51
Snapshot of Competing Players 52
Ping An Insurance (Group) Company of China, Ltd 52
Key Company Facts 52
Company Description 52
Snapshot of Competing Players 53
Shanghai Pharmaceuticals Holding Co., Ltd 53
Key Company Facts 53
Company Description 53
Fosun International Ltd - In the News 54
22-Aug-2025 -First Subject Dosed in the US for a Phase 2 International Clinical Trial of Henlius' PD-L1 ADC HLX43 for NSCLC 54
07-Aug-2025 -Henlius to Initiate a Phase 1 Multicenter Study in US of Its PD-L1 ADC HLX43 for the Treatment of Thymic Carcinoma 56
21-Jul-2025 -Club Med appoints Stephane Maquaire as President and CEO 58
24-Jun-2025 -Serplulimab Approved in the UK and India for the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer 60
29-May-2025 -Fosun Pharma's Self-Developed Innovative Drug Luvometinib Tablet Approved in China 61
10-Apr-2025 -Finloop Becomes a Strategic Enterprise of OASES 62
19-Mar-2025 -Henlius Receives Orphan-Drug Designation for HLX22 (Innovative anti-HER2 mAb) in the U.S. for Gastric Cancer 64
19-Feb-2025 -Henlius Bevacizumab Secures First Overseas Approval, Accelerating Henlius' Expansion into Latin American Market 66
14-Feb-2025 -Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation 66
05-Feb-2025 -Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) 68
Fosun International Ltd- Key Deals 70
31-Jul-2025 - Fosun Tourism Group Signs Syndicated Loan Agreement with Seven International Banks 70
03-Jul-2025 - Henlius and HanchorBio Collaborate to Develop Novel SIRP?-Fc Fusion Protein, Expanding Tumor Immunotherapy Layout 71
06-Feb-2025 - Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S 73
16-Jan-2025 - Fosun International Enters into Strategic Cooperation Agreement with Natixis CIB 75
Appendix 77
Definitions 77
SWOT Analysis 77
PESTLE Analysis 77
Value Chain Analysis 77
ESG Spotlight 77
Financial Deep Dive 77
Financial Ratios - 78
Activity Ratios 78
Growth Ratios 79
Leverage Ratios 80
Liquidity Ratios 81
Market Ratios 82
Profitability Ratios 82
Research Methodology 83
Disclaimer 84
Contact Us 84

Table 1: Fosun International Ltd - Company Facts 7
Table 2: Fosun International Ltd - Digital Presence 7
Table 3: Fosun International Ltd - Top Executives 9
Table 4: Fosun International Ltd - Products 11
Table 5: Fosun International Ltd - Services 12
Table 6: Fosun International Ltd - Share Price Trend - Dec-2024 to Dec-2025 35
Table 7: Fosun International Ltd- Ratio Analysis - 2021-2024 43
Table 8: Fosun International Ltd -Competing Players 49
Table 9: Competing Players - China Everbright Ltd - Key Company Facts 50
Table 10: Competing Players - Marriott International Inc. - Key Company Facts 51
Table 11: Competing Players - Ping An Insurance (Group) Company of China, Ltd. - Key Company Facts 52
Table 12: Competing Players - Shanghai Pharmaceuticals Holding Co., Ltd - Key Company Facts 53

Figure 1: Fosun International Ltd- SWOT Analysis 25
Figure 2: Fosun International Ltd - Average Share Price Trend - Dec-2024 to Dec-2025 36
Figure 3: Fosun International Ltd - Profit and Loss Statement - 2021-2024 38
Figure 4: Fosun International Ltd - Balance Sheet - 2021-2024 40
Figure 5: Fosun International Ltd - Cash Flow Statement 2021-2024 42
Figure 6: Fosun International Ltd - Activity Ratio Charts 44
Figure 7: Fosun International Ltd - Growth Ratio Charts (Value %) 45
Figure 8: Fosun International Ltd - Leverage Ratio Charts 46
Figure 9: Fosun International Ltd - Liquidity Ratio Charts 47
Figure 10: Fosun International Ltd - Profitability Ratio Charts (Value %) 48

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE